Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Elez Marija"'
Publikováno v:
Srpski Arhiv za Celokupno Lekarstvo, Vol 149, Iss 1-2, Pp 74-77 (2021)
Introduction. Adult-onset Still’s disease is a rare inflammatory disorder of unknown etiology. It can be complicated by macrophage activation syndrome, a potentially life-threatening condition. While macrophage activation syndrome and adult-onset S
Externí odkaz:
https://doaj.org/article/ba72d39193774b89b60a6a35faded890
Autor:
Milev Boško, Milev Borka, Kostić Zoran, Mirković Darko, Perišić Nenad, Tasić Olga, Elez Marija, Radunović Aleksandar, Jovanović Milan, Marić Predrag, Daišević Sanja, Prelević Rade, Vulović Maja
Publikováno v:
Vojnosanitetski Pregled, Vol 74, Iss 4, Pp 367-370 (2017)
Introduction. Castleman disease is a rare disease of the unknown etiology, occuring in two clinical forms: unicentric or multicentric. It is characterized by the hyperplasia of lymph glands. In literature the four pathohistological forms were desc
Externí odkaz:
https://doaj.org/article/47adfb929b944338ad23c2afc29a361b
Autor:
Obradović Dragana, Tukić Ljiljana, Radovinović-Tasić Sanja, Petrović Boris, Elez Marija, Ostojić Gordana, Balint Bela
Publikováno v:
Vojnosanitetski Pregled, Vol 73, Iss 5, Pp 504-508 (2016)
Introduction. Multiple sclerosis (MS) is an immunemediated disease of the central nervous system that affects young individuals and leads to severe disability. High dose immunoablation followed by autologous hemopoietic stem cell transplantation (
Externí odkaz:
https://doaj.org/article/13db0fd9007545a688f38c5b474842c6
Autor:
Stamatović Dragana, Balint Bela, Tukić Ljiljana, Elez Marija, Tarabar Olivera, Todorović Milena, Todorić-Živanović Biljana, Ostojić Gordana, Tatomirović Željka, Marjanović Slobodan, Malešević Milomir
Publikováno v:
Vojnosanitetski Pregled, Vol 69, Iss 1, Pp 37-42 (2012)
Background/Aim. Introducing tyrosine kinase inhibitors (TKIs) has essentially changed curative approach, to be precise, clearly improved treatment efficacy for chronic myeloid leukemia (CML). Thus, the place and usage of allogeneic stem cell transpla
Externí odkaz:
https://doaj.org/article/9c61041ee92b42448e0afa91d03e9ed6
Autor:
Stamatović Dragana, Balint Bela, Tukić Ljiljana, Elez Marija, Tarabar Olivera, Todorović Milena, Ostojić Gordana, Tatomirović Zeljka, Ljubenov Marika, Marjanović Slobodan, Malešević Milomir
Publikováno v:
Vojnosanitetski Pregled, Vol 68, Iss 12, Pp 1026-1032 (2011)
Background/Aim. Peripheral blood (PB) is used more frequently as a source of stem cells (SCs) for allogeneic transplantation. However, the influence of cell source on the clinical outcome of SC transplantation is not yet well established. The aim of
Externí odkaz:
https://doaj.org/article/4311a808c27248f3a49f2992212c97ab
Autor:
Marjanović Slobodan, Stamatović Dragana, Tukić Ljiljana, Tarabar Olivera, Elez Marija, Mađaru Lavinika, Balint Bela, Tatomirović Željka, Kuljić-Kapulica Nada, Anđelković Nebojša
Publikováno v:
Vojnosanitetski Pregled, Vol 68, Iss 5, Pp 387-392 (2011)
Background/Aim. In comparison to standard therapy autologous stem cell transplant (ASCT) with high doses melphalane has improved treatment of multiple myeloma (MM) patients. The aim of this study was to evaluate the results of treatment of MM patient
Externí odkaz:
https://doaj.org/article/9fc4a7e554754341a14ff8dc38957c68
Autor:
Tarabar Olivera, Tukić Ljiljana, Stamatović Dragana, Balint Bela, Elez Marija, Ostojić Gordana, Tatomirović Željka, Marjanović Slobodan
Publikováno v:
Vojnosanitetski Pregled, Vol 66, Iss 7, Pp 571-576 (2009)
Background/Aim. High-dose chemotherapy with autologous stem cell transplantacion (ASCT) has shown to produce long-term disease-free survival in patients with chemotherapysensitive Hodgkin disease. The aim of the study was to evaluate efficacy of ASCT
Externí odkaz:
https://doaj.org/article/b380540382b64e6c96e010ad7a22919a
Autor:
Tukić Ljiljana, Stamatović Dragana, Tarabar Olivera, Elez Marija, Zorić Miodrag, Mandić-Radić Slavka
Publikováno v:
Vojnosanitetski Pregled, Vol 62, Iss 7-8, Pp 587-590 (2005)
Background. Factor V (FV) inhibitors are a rare disorder reported for the first time about fifty years ago, mostly with the unknown cause. The appearance of FV inhibitors is usually preceded by surgery, infections, administration of antibiotics or tr
Externí odkaz:
https://doaj.org/article/b453fd7baf684bc2b5af865ec1146957
Autor:
ELEZ, Marija1 drmarija.elez@gmail.com, TODOROVIĆ BALINT, Milena2,3
Publikováno v:
Medical Review / Medicinski Pregled. 2022 Supplement, Vol. 75, p54-56. 3p.
Autor:
Balint, Bela, Stamatovic, Dragana, Todorovic, Milena, Elez, Marija, Vojvodic, Danilo, Pavlovic, Mirjana, Cucuz-Jokic, Milica
Publikováno v:
In Transfusion and Apheresis Science 2011 45(2):137-141